Clinical Trial Update: An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

View source ↗

Summary

An observational real-world cohort study evaluated the safety and efficacy of Micardis (telmisartan) taken once daily at 40 mg/day and 80 mg/day in hypertensive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED | Results posted: 2010-03-24